April 5, 2026 2:34 PM
Latest:
  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness
  • Equinox Ups Its Offer For Calibre: Investors Said No!
  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash
  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win
  • Agnico Eagle Q1 Earnings: Costs Go Down?!
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

  • Home
  • Latest
    • Automotive
    • Cannabis
    • Commentary
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Resources
    • Technology
  • Resources
  • Energy
  • Technology
  • Coverage Companies
    • Brazil Potash
    • Canadian Copper
    • Cardiol Therapeutics
    • Cytophage Technologies
    • ESGold Corp
    • First Majestic Silver
    • Golden Cariboo Resources
    • Nations Royalty Corp
    • Plurilock Security
    • Power Metallic
    • PTX Metals
    • Riverside Resources
    • Rua Gold
    • Silver47 Exploration
    • Sonoro Gold
    • Spirit Blockchain
    • Temas Resources
  • Verses AI
  • About
  • Contact Us

Ozempic

Latest Macro 

WeightWatchers Prepares For Bankruptcy Protection As It Loses Ground to Ozempic

April 24, 2025 7:59 AMApril 24, 2025 7:59 AM JP Alegre 0 Comments bankruptcies, Ozempic, WeightWatchers International Inc

WeightWatchers International Inc. is preparing to file for bankruptcy within weeks after securing a debt-restructuring agreement with most of its

Share
Tweet
Share
Reddit
Read more
Food Healthcare Latest Macro 

Big Food Scrambles to Adapt as Weight Loss Drugs Transform Appetites

February 14, 2025 11:01 AMFebruary 14, 2025 10:01 AM JP Alegre 0 Comments big food, GLP-1 drugs, Novo Nordisk, Ozempic, Wegovy

Say hello to ‘Ozempic-proof’ foods

Share
Tweet
Share
Reddit
Read more
Latest Macro 

Study Examines Vision Loss Reports in Patients Taking GLP-1 Drugs

February 12, 2025 2:14 PMFebruary 12, 2025 10:02 AM JP Alegre 0 Comments GLP-1 drugs, Mounjaro, Novo Nordisk, Ozempic

A new JAMA study is investigating ophthalmic complications in patients using semaglutide and tirzepatide, the active ingredients in drugs like

Share
Tweet
Share
Reddit
Read more
Biotech Latest 

People Are Overdosing On Ozempic and Its Off-Brand Versions

December 14, 2023 12:31 PMDecember 14, 2023 12:09 PM JP Alegre 0 Comments Novo Nordisk, Ozempic, semaglutide, Wegovy

Ozempic for diabetes and Wegovy for weight loss have been so wildly in demand that the drugs boosted the GDP

Share
Tweet
Share
Reddit
Read more
Healthcare Latest 

FDA Approves Wegovy Competitor from Eli Lilly

November 9, 2023 2:02 PMNovember 9, 2023 12:14 PM JP Alegre 0 Comments Eli Lilly, Ozempic, Wegovy, Zepbound

The US Food and Drug Administration (FDA) has granted approval for the use of tirzepatide, a type 2 diabetes drug,

Share
Tweet
Share
Reddit
Read more
Biotech Food Latest 

Can Ozempic Topple Fast Food Demand?

November 3, 2023 3:59 PMNovember 3, 2023 1:45 PM JP Alegre 0 Comments Fast Food Industry, Novo Nordisk, Ozempic, QSR Industry

GLP-1 medications like Ozempic and Wegovy could mean serious trouble for the quick-service restaurant (QSR) industry. Recent insights from Earnest

Share
Tweet
Share
Reddit
Read more
Biotech Latest 

Is Ozempic the New Wonder Drug?

May 22, 2023 3:27 PMMay 22, 2023 10:14 AM JP Alegre 0 Comments Novo Nordisk, Ozempic, Wegovy

Ozempic has been all the rage lately. It’s become synonymous with weight loss, and lately, as a possible cure-all for

Share
Tweet
Share
Reddit
Read more

Latest

  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness

  • Equinox Ups Its Offer For Calibre: Investors Said No!

  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash

  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win

  • Agnico Eagle Q1 Earnings: Costs Go Down?!

  • Why Gold Is Secretly Flooding Into The U.S. & Who’s Suppressing Silver?! | Andy Schectman

  • Gold @ $3500: All We Need Is $700 To Break Even! | Brad Kitchen – ESGOLD Corp.

  • Canada Is Nearly Last In Growth Among OECD Countries

Video

Teck Resources Q1 Earnings: Defying Copper Industry Weakness
Full Analysis Latest Resources Video Series 

Teck Resources Q1 Earnings: Defying Copper Industry Weakness

April 27, 2025 4:40 PM Jay Lutz 0

Yesterday in our coverage of First Quantum Mining’s business we said it was a terrible time to be a copper

Trending

  • Annie Altman, OpenAI CEO's Sister, Tweets About Sexual Abuse Suffered From "Brother" Sam Altman
  • A Car Dealership in California Is Using ChatGPT for Customer Support, and People…Took Advantage
  • Filament Health Walks Away From SPAC Merger, US$14.4 Million Financing
  • Commodities And The New World Order: What You Need To Know From Zoltan Pozsar's Bretton Woods III
  • X Changes Policy to Now Allow Adult Content

News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial
Biotech Latest News 

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek
Latest News Resources 

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0
Canadian Copper To Begin Exploration At Murray Brook East
Latest News Resources 

Canadian Copper To Begin Exploration At Murray Brook East

April 15, 2025 10:30 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Bonds
  • Cannabis
  • Commentary
  • Crypto
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Latest
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2026 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.